Vulnerability-Lookup

CVE-2026-52866 (GCVE-0-2026-52866)

Vulnerability from cvelistv5 – Published: 2026-06-18 23:45 – Updated: 2026-06-22 14:52

Title

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization

Summary

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

Severity

6.5 (Medium)


                        
                          CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

7.1 (High)


                        
                          CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N

SSVC

Exploitation: none Automatable: no Technical Impact: partial

CISA Coordinator · CISA-ADP (v2.0.3)

Decision recorded 2026-06-22 14:51 UTC

CWE

CWE-862

Assigner

icscert icscert root

References

4 references

URL	Tags
https://www.apollopharmacy.in/contact-us
https://www.cisa.gov/news-events/news/understandi…
https://www.cisa.gov/news-events/ics-medical-advi…
https://github.com/cisagov/CSAF/blob/develop/csaf…

Impacted products

1 product

Vendor	Product	Version	CPE status
Apollo Pharmacy	Blood Glucose Monitoring System (Model No. APG-01 BT)	Affected: 0x0110_v1.1.0	guessed

Credits

Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.

Show details on NVD website

JSON

To clipboard

{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-52866",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "no"
                  },
                  {
                    "Technical Impact": "partial"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-06-22T14:51:51.052831Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-06-22T14:52:06.602Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "defaultStatus": "unaffected",
          "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)",
          "vendor": "Apollo Pharmacy",
          "versions": [
            {
              "status": "affected",
              "version": "0x0110_v1.1.0"
            }
          ]
        }
      ],
      "credits": [
        {
          "lang": "en",
          "type": "finder",
          "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA."
        }
      ],
      "descriptions": [
        {
          "lang": "en",
          "supportingMedia": [
            {
              "base64": false,
              "type": "text/html",
              "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
            }
          ],
          "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "ADJACENT_NETWORK",
            "availabilityImpact": "HIGH",
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "confidentialityImpact": "NONE",
            "integrityImpact": "NONE",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H",
            "version": "3.1"
          },
          "format": "CVSS",
          "scenarios": [
            {
              "lang": "en",
              "value": "GENERAL"
            }
          ]
        },
        {
          "cvssV4_0": {
            "Automatable": "NOT_DEFINED",
            "Recovery": "NOT_DEFINED",
            "Safety": "NOT_DEFINED",
            "attackComplexity": "LOW",
            "attackRequirements": "NONE",
            "attackVector": "ADJACENT",
            "baseScore": 7.1,
            "baseSeverity": "HIGH",
            "exploitMaturity": "NOT_DEFINED",
            "privilegesRequired": "NONE",
            "providerUrgency": "NOT_DEFINED",
            "subAvailabilityImpact": "NONE",
            "subConfidentialityImpact": "NONE",
            "subIntegrityImpact": "NONE",
            "userInteraction": "NONE",
            "valueDensity": "NOT_DEFINED",
            "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N",
            "version": "4.0",
            "vulnAvailabilityImpact": "HIGH",
            "vulnConfidentialityImpact": "NONE",
            "vulnIntegrityImpact": "NONE",
            "vulnerabilityResponseEffort": "NOT_DEFINED"
          },
          "format": "CVSS",
          "scenarios": [
            {
              "lang": "en",
              "value": "GENERAL"
            }
          ]
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "cweId": "CWE-862",
              "description": "CWE-862",
              "lang": "en",
              "type": "CWE"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-06-18T23:45:34.263Z",
        "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "shortName": "icscert"
      },
      "references": [
        {
          "url": "https://www.apollopharmacy.in/contact-us"
        },
        {
          "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
        },
        {
          "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
        },
        {
          "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
        }
      ],
      "source": {
        "advisory": "ICSMA-26-169-01",
        "discovery": "EXTERNAL"
      },
      "title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization",
      "workarounds": [
        {
          "lang": "en",
          "supportingMedia": [
            {
              "base64": false,
              "type": "text/html",
              "value": "\u003cp\u003eApollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\u003cbr\u003e\u003ca href=\"https://www.apollopharmacy.in/contact-us\"\u003ehttps://www.apollopharmacy.in/contact-us\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003eCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u0026nbsp;\u003cbr\u003e\u003ca href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\"\u003ehttps://www.cisa.gov/news-events/news/understanding-bluetooth-technology\u003c/a\u003e\u003c/p\u003e"
            }
          ],
          "value": "Apollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
        }
      ],
      "x_generator": {
        "engine": "Vulnogram 1.0.2"
      }
    }
  },
  "cveMetadata": {
    "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
    "assignerShortName": "icscert",
    "cveId": "CVE-2026-52866",
    "datePublished": "2026-06-18T23:45:34.263Z",
    "dateReserved": "2026-06-10T21:21:12.261Z",
    "dateUpdated": "2026-06-22T14:52:06.602Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2",
  "vulnerability-lookup:meta": {
    "epss": {
      "cve": "CVE-2026-52866",
      "date": "2026-09-16",
      "epss": "0.00348",
      "percentile": "0.28195"
    },
    "nvd": "{\"cve\":{\"id\":\"CVE-2026-52866\",\"sourceIdentifier\":\"ics-cert@hq.dhs.gov\",\"published\":\"2026-06-19T00:16:48.123\",\"lastModified\":\"2026-06-22T20:30:53.723\",\"vulnStatus\":\"Awaiting Analysis\",\"cveTags\":[],\"descriptions\":[{\"lang\":\"en\",\"value\":\"An attacker within BLE communication range can monopolize the device\u0027s \\nonly available BLE connection slot, preventing legitimate users or \\napplications from establishing a connection.\"}],\"affected\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"affectedData\":[{\"vendor\":\"Apollo Pharmacy\",\"product\":\"Blood Glucose Monitoring System (Model No. APG-01 BT)\",\"defaultStatus\":\"unaffected\",\"versions\":[{\"version\":\"0x0110_v1.1.0\",\"status\":\"affected\"}]}]}],\"metrics\":{\"cvssMetricV40\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"4.0\",\"vectorString\":\"CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X\",\"baseScore\":7.1,\"baseSeverity\":\"HIGH\",\"attackVector\":\"ADJACENT\",\"attackComplexity\":\"LOW\",\"attackRequirements\":\"NONE\",\"privilegesRequired\":\"NONE\",\"userInteraction\":\"NONE\",\"vulnConfidentialityImpact\":\"NONE\",\"vulnIntegrityImpact\":\"NONE\",\"vulnAvailabilityImpact\":\"HIGH\",\"subConfidentialityImpact\":\"NONE\",\"subIntegrityImpact\":\"NONE\",\"subAvailabilityImpact\":\"NONE\",\"exploitMaturity\":\"NOT_DEFINED\",\"confidentialityRequirement\":\"NOT_DEFINED\",\"integrityRequirement\":\"NOT_DEFINED\",\"availabilityRequirement\":\"NOT_DEFINED\",\"modifiedAttackVector\":\"NOT_DEFINED\",\"modifiedAttackComplexity\":\"NOT_DEFINED\",\"modifiedAttackRequirements\":\"NOT_DEFINED\",\"modifiedPrivilegesRequired\":\"NOT_DEFINED\",\"modifiedUserInteraction\":\"NOT_DEFINED\",\"modifiedVulnConfidentialityImpact\":\"NOT_DEFINED\",\"modifiedVulnIntegrityImpact\":\"NOT_DEFINED\",\"modifiedVulnAvailabilityImpact\":\"NOT_DEFINED\",\"modifiedSubConfidentialityImpact\":\"NOT_DEFINED\",\"modifiedSubIntegrityImpact\":\"NOT_DEFINED\",\"modifiedSubAvailabilityImpact\":\"NOT_DEFINED\",\"Safety\":\"NOT_DEFINED\",\"Automatable\":\"NOT_DEFINED\",\"Recovery\":\"NOT_DEFINED\",\"valueDensity\":\"NOT_DEFINED\",\"vulnerabilityResponseEffort\":\"NOT_DEFINED\",\"providerUrgency\":\"NOT_DEFINED\"}}],\"cvssMetricV31\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"3.1\",\"vectorString\":\"CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H\",\"baseScore\":6.5,\"baseSeverity\":\"MEDIUM\",\"attackVector\":\"ADJACENT_NETWORK\",\"attackComplexity\":\"LOW\",\"privilegesRequired\":\"NONE\",\"userInteraction\":\"NONE\",\"scope\":\"UNCHANGED\",\"confidentialityImpact\":\"NONE\",\"integrityImpact\":\"NONE\",\"availabilityImpact\":\"HIGH\"},\"exploitabilityScore\":2.8,\"impactScore\":3.6}],\"ssvcV203\":[{\"source\":\"134c704f-9b21-4f2e-91b3-4a467353bcc0\",\"ssvcData\":{\"timestamp\":\"2026-06-22T14:51:51.052831Z\",\"id\":\"CVE-2026-52866\",\"options\":[{\"exploitation\":\"none\"},{\"automatable\":\"no\"},{\"technicalImpact\":\"partial\"}],\"role\":\"CISA Coordinator\",\"version\":\"2.0.3\"}}]},\"weaknesses\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"description\":[{\"lang\":\"en\",\"value\":\"CWE-862\"}]}],\"references\":[{\"url\":\"https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json\",\"source\":\"ics-cert@hq.dhs.gov\"},{\"url\":\"https://www.apollopharmacy.in/contact-us\",\"source\":\"ics-cert@hq.dhs.gov\"},{\"url\":\"https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01\",\"source\":\"ics-cert@hq.dhs.gov\"},{\"url\":\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\",\"source\":\"ics-cert@hq.dhs.gov\"}]}}",
    "vulnrichment": {
      "containers": "{\"adp\": [{\"title\": \"CISA ADP Vulnrichment\", \"metrics\": [{\"other\": {\"type\": \"ssvc\", \"content\": {\"id\": \"CVE-2026-52866\", \"role\": \"CISA Coordinator\", \"options\": [{\"Exploitation\": \"none\"}, {\"Automatable\": \"no\"}, {\"Technical Impact\": \"partial\"}], \"version\": \"2.0.3\", \"timestamp\": \"2026-06-22T14:51:51.052831Z\"}}}], \"providerMetadata\": {\"orgId\": \"134c704f-9b21-4f2e-91b3-4a467353bcc0\", \"shortName\": \"CISA-ADP\", \"dateUpdated\": \"2026-06-22T14:51:59.764Z\"}}], \"cna\": {\"title\": \"Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization\", \"source\": {\"advisory\": \"ICSMA-26-169-01\", \"discovery\": \"EXTERNAL\"}, \"credits\": [{\"lang\": \"en\", \"type\": \"finder\", \"value\": \"Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.\"}], \"metrics\": [{\"format\": \"CVSS\", \"cvssV3_1\": {\"scope\": \"UNCHANGED\", \"version\": \"3.1\", \"baseScore\": 6.5, \"attackVector\": \"ADJACENT_NETWORK\", \"baseSeverity\": \"MEDIUM\", \"vectorString\": \"CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H\", \"integrityImpact\": \"NONE\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"availabilityImpact\": \"HIGH\", \"privilegesRequired\": \"NONE\", \"confidentialityImpact\": \"NONE\"}, \"scenarios\": [{\"lang\": \"en\", \"value\": \"GENERAL\"}]}, {\"format\": \"CVSS\", \"cvssV4_0\": {\"Safety\": \"NOT_DEFINED\", \"version\": \"4.0\", \"Recovery\": \"NOT_DEFINED\", \"baseScore\": 7.1, \"Automatable\": \"NOT_DEFINED\", \"attackVector\": \"ADJACENT\", \"baseSeverity\": \"HIGH\", \"valueDensity\": \"NOT_DEFINED\", \"vectorString\": \"CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N\", \"exploitMaturity\": \"NOT_DEFINED\", \"providerUrgency\": \"NOT_DEFINED\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"attackRequirements\": \"NONE\", \"privilegesRequired\": \"NONE\", \"subIntegrityImpact\": \"NONE\", \"vulnIntegrityImpact\": \"NONE\", \"subAvailabilityImpact\": \"NONE\", \"vulnAvailabilityImpact\": \"HIGH\", \"subConfidentialityImpact\": \"NONE\", \"vulnConfidentialityImpact\": \"NONE\", \"vulnerabilityResponseEffort\": \"NOT_DEFINED\"}, \"scenarios\": [{\"lang\": \"en\", \"value\": \"GENERAL\"}]}], \"affected\": [{\"vendor\": \"Apollo Pharmacy\", \"product\": \"Blood Glucose Monitoring System (Model No. APG-01 BT)\", \"versions\": [{\"status\": \"affected\", \"version\": \"0x0110_v1.1.0\"}], \"defaultStatus\": \"unaffected\"}], \"references\": [{\"url\": \"https://www.apollopharmacy.in/contact-us\"}, {\"url\": \"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\"}, {\"url\": \"https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01\"}, {\"url\": \"https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json\"}], \"workarounds\": [{\"lang\": \"en\", \"value\": \"Apollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \\nUsers are encouraged to reach out to Apollo Pharmacy directly for more \\ninformation:\\n https://www.apollopharmacy.in/contact-us \\n\\n\\n\\n\\n\\nCISA recommends users follow the \\nguidance in the Understanding Bluetooth Technology blog:\\u00a0\\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\", \"supportingMedia\": [{\"type\": \"text/html\", \"value\": \"\u003cp\u003eApollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \\nUsers are encouraged to reach out to Apollo Pharmacy directly for more \\ninformation:\u003cbr\u003e\u003ca href=\\\"https://www.apollopharmacy.in/contact-us\\\"\u003ehttps://www.apollopharmacy.in/contact-us\u003c/a\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cbr\u003eCISA recommends users follow the \\nguidance in the Understanding Bluetooth Technology blog:\u0026nbsp;\u003cbr\u003e\u003ca href=\\\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\\\"\u003ehttps://www.cisa.gov/news-events/news/understanding-bluetooth-technology\u003c/a\u003e\u003c/p\u003e\", \"base64\": false}]}], \"x_generator\": {\"engine\": \"Vulnogram 1.0.2\"}, \"descriptions\": [{\"lang\": \"en\", \"value\": \"An attacker within BLE communication range can monopolize the device\u0027s \\nonly available BLE connection slot, preventing legitimate users or \\napplications from establishing a connection.\", \"supportingMedia\": [{\"type\": \"text/html\", \"value\": \"An attacker within BLE communication range can monopolize the device\u0027s \\nonly available BLE connection slot, preventing legitimate users or \\napplications from establishing a connection.\", \"base64\": false}]}], \"problemTypes\": [{\"descriptions\": [{\"lang\": \"en\", \"type\": \"CWE\", \"cweId\": \"CWE-862\", \"description\": \"CWE-862\"}]}], \"providerMetadata\": {\"orgId\": \"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6\", \"shortName\": \"icscert\", \"dateUpdated\": \"2026-06-18T23:45:34.263Z\"}}}",
      "cveMetadata": "{\"cveId\": \"CVE-2026-52866\", \"state\": \"PUBLISHED\", \"dateUpdated\": \"2026-06-22T14:52:06.602Z\", \"dateReserved\": \"2026-06-10T21:21:12.261Z\", \"assignerOrgId\": \"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6\", \"datePublished\": \"2026-06-18T23:45:34.263Z\", \"assignerShortName\": \"icscert\"}",
      "dataType": "CVE_RECORD",
      "dataVersion": "5.2"
    }
  }
}

FKIE_CVE-2026-52866

Vulnerability from fkie_nvd - Published: 2026-06-19 00:16 - Updated: 2026-06-22 20:30

Severity

6.5 (Medium) - CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Summary

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

References

	URL	Tags
	ics-cert@hq.dhs.gov	https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json
	ics-cert@hq.dhs.gov	https://www.apollopharmacy.in/contact-us
	ics-cert@hq.dhs.gov	https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01
	ics-cert@hq.dhs.gov	https://www.cisa.gov/news-events/news/understanding-bluetooth-technology

Impacted products

	Vendor	Product	Version

JSON

To clipboard

{
  "affected": [
    {
      "affectedData": [
        {
          "defaultStatus": "unaffected",
          "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)",
          "vendor": "Apollo Pharmacy",
          "versions": [
            {
              "status": "affected",
              "version": "0x0110_v1.1.0"
            }
          ]
        }
      ],
      "source": "ics-cert@hq.dhs.gov"
    }
  ],
  "cveTags": [],
  "descriptions": [
    {
      "lang": "en",
      "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
    }
  ],
  "id": "CVE-2026-52866",
  "lastModified": "2026-06-22T20:30:53.723",
  "metrics": {
    "cvssMetricV31": [
      {
        "cvssData": {
          "attackComplexity": "LOW",
          "attackVector": "ADJACENT_NETWORK",
          "availabilityImpact": "HIGH",
          "baseScore": 6.5,
          "baseSeverity": "MEDIUM",
          "confidentialityImpact": "NONE",
          "integrityImpact": "NONE",
          "privilegesRequired": "NONE",
          "scope": "UNCHANGED",
          "userInteraction": "NONE",
          "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H",
          "version": "3.1"
        },
        "exploitabilityScore": 2.8,
        "impactScore": 3.6,
        "source": "ics-cert@hq.dhs.gov",
        "type": "Secondary"
      }
    ],
    "cvssMetricV40": [
      {
        "cvssData": {
          "Automatable": "NOT_DEFINED",
          "Recovery": "NOT_DEFINED",
          "Safety": "NOT_DEFINED",
          "attackComplexity": "LOW",
          "attackRequirements": "NONE",
          "attackVector": "ADJACENT",
          "availabilityRequirement": "NOT_DEFINED",
          "baseScore": 7.1,
          "baseSeverity": "HIGH",
          "confidentialityRequirement": "NOT_DEFINED",
          "exploitMaturity": "NOT_DEFINED",
          "integrityRequirement": "NOT_DEFINED",
          "modifiedAttackComplexity": "NOT_DEFINED",
          "modifiedAttackRequirements": "NOT_DEFINED",
          "modifiedAttackVector": "NOT_DEFINED",
          "modifiedPrivilegesRequired": "NOT_DEFINED",
          "modifiedSubAvailabilityImpact": "NOT_DEFINED",
          "modifiedSubConfidentialityImpact": "NOT_DEFINED",
          "modifiedSubIntegrityImpact": "NOT_DEFINED",
          "modifiedUserInteraction": "NOT_DEFINED",
          "modifiedVulnAvailabilityImpact": "NOT_DEFINED",
          "modifiedVulnConfidentialityImpact": "NOT_DEFINED",
          "modifiedVulnIntegrityImpact": "NOT_DEFINED",
          "privilegesRequired": "NONE",
          "providerUrgency": "NOT_DEFINED",
          "subAvailabilityImpact": "NONE",
          "subConfidentialityImpact": "NONE",
          "subIntegrityImpact": "NONE",
          "userInteraction": "NONE",
          "valueDensity": "NOT_DEFINED",
          "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
          "version": "4.0",
          "vulnAvailabilityImpact": "HIGH",
          "vulnConfidentialityImpact": "NONE",
          "vulnIntegrityImpact": "NONE",
          "vulnerabilityResponseEffort": "NOT_DEFINED"
        },
        "source": "ics-cert@hq.dhs.gov",
        "type": "Secondary"
      }
    ],
    "ssvcV203": [
      {
        "source": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
        "ssvcData": {
          "id": "CVE-2026-52866",
          "options": [
            {
              "exploitation": "none"
            },
            {
              "automatable": "no"
            },
            {
              "technicalImpact": "partial"
            }
          ],
          "role": "CISA Coordinator",
          "timestamp": "2026-06-22T14:51:51.052831Z",
          "version": "2.0.3"
        }
      }
    ]
  },
  "published": "2026-06-19T00:16:48.123",
  "references": [
    {
      "source": "ics-cert@hq.dhs.gov",
      "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
    },
    {
      "source": "ics-cert@hq.dhs.gov",
      "url": "https://www.apollopharmacy.in/contact-us"
    },
    {
      "source": "ics-cert@hq.dhs.gov",
      "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
    },
    {
      "source": "ics-cert@hq.dhs.gov",
      "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
    }
  ],
  "sourceIdentifier": "ics-cert@hq.dhs.gov",
  "vulnStatus": "Awaiting Analysis",
  "weaknesses": [
    {
      "description": [
        {
          "lang": "en",
          "value": "CWE-862"
        }
      ],
      "source": "ics-cert@hq.dhs.gov",
      "type": "Secondary"
    }
  ]
}

GHSA-47R7-422P-6W2P

Vulnerability from github – Published: 2026-06-19 00:31 – Updated: 2026-06-19 00:31

Details

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

Severity

6.5 (Medium)


                  
                    CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

7.1 (High)


                  
                    CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N

Show details on source website

JSON

To clipboard

{
  "affected": [],
  "aliases": [
    "CVE-2026-52866"
  ],
  "database_specific": {
    "cwe_ids": [
      "CWE-862"
    ],
    "github_reviewed": false,
    "github_reviewed_at": null,
    "nvd_published_at": "2026-06-19T00:16:48Z",
    "severity": "HIGH"
  },
  "details": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection.",
  "id": "GHSA-47r7-422p-6w2p",
  "modified": "2026-06-19T00:31:38Z",
  "published": "2026-06-19T00:31:38Z",
  "references": [
    {
      "type": "ADVISORY",
      "url": "https://nvd.nist.gov/vuln/detail/CVE-2026-52866"
    },
    {
      "type": "WEB",
      "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
    },
    {
      "type": "WEB",
      "url": "https://www.apollopharmacy.in/contact-us"
    },
    {
      "type": "WEB",
      "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
    },
    {
      "type": "WEB",
      "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
    }
  ],
  "schema_version": "1.4.0",
  "severity": [
    {
      "score": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H",
      "type": "CVSS_V3"
    },
    {
      "score": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
      "type": "CVSS_V4"
    }
  ]
}

ICSMA-26-169-01

Vulnerability from csaf_cisa - Published: 2026-06-18 06:00 - Updated: 2026-06-18 06:00

Summary

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT

Scope

2 vulnerabilities in this advisory, including CVE-2026-52866.

CVE-2026-52866

6.5 (Medium)


                
                  CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Known affected: 1 product

https://www.apollopharmacy.in/contact-us https://www.cisa.gov/news-events/news/understanding-bluetoo…

Open the full advisory

Sightings

Author	Source	Type	Date	Other

Nomenclature

Seen: The vulnerability was mentioned, discussed, or observed by the user.
Confirmed: The vulnerability has been validated from an analyst's perspective.
Published Proof of Concept: A public proof of concept is available for this vulnerability.
Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
Not confirmed: The user expressed doubt about the validity of the vulnerability.
Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.

Detection rules are retrieved from Rulezet.

The MITRE ATT&CK techniques below are AI-generated suggestions, inferred from the description of the vulnerability by the CIRCL/vulnerability-attack-technique-classification-roberta-base model, served locally by ML-Gateway. They have not been verified by an analyst and are provided for guidance only.
The approach is described in our paper Mapping CVEs to MITRE ATT&CK Techniques: A Curated Gold-Set Classifier and the Limits of LLM-Assisted Label Expansion.
Browse all ATT&CK techniques and the vulnerabilities related to each.

Related by attack behaviour

Vulnerabilities whose description is nearest to this one in the vector space of the CIRCL/vulnerability-attack-technique-biencoder model. This is a similarity search over the bi-encoder space (plain cosine), not a classification, and it has no measured accuracy.

Action not permitted

CVE-2026-52866 (GCVE-0-2026-52866)

FKIE_CVE-2026-52866

GHSA-47R7-422P-6W2P

ICSMA-26-169-01

Tags

Sightings

Nomenclature

Related by attack behaviour